Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Serotonin receptor 1A–modulated phosphorylation of glycine receptor α3 controls breathing in mice
Till Manzke, … , Robert J. Harvey, Diethelm W. Richter
Till Manzke, … , Robert J. Harvey, Diethelm W. Richter
Published October 11, 2010
Citation Information: J Clin Invest. 2010;120(11):4118-4128. https://doi.org/10.1172/JCI43029.
View: Text | PDF
Research Article Pulmonology

Serotonin receptor 1A–modulated phosphorylation of glycine receptor α3 controls breathing in mice

  • Text
  • PDF
Abstract

Rhythmic breathing movements originate from a dispersed neuronal network in the medulla and pons. Here, we demonstrate that rhythmic activity of this respiratory network is affected by the phosphorylation status of the inhibitory glycine receptor α3 subtype (GlyRα3), which controls glutamatergic and glycinergic neuronal discharges, subject to serotonergic modulation. Serotonin receptor type 1A–specific (5-HTR1A–specific) modulation directly induced dephosphorylation of GlyRα3 receptors, which augmented inhibitory glycine-activated chloride currents in HEK293 cells coexpressing 5-HTR1A and GlyRα3. The 5-HTR1A–GlyRα3 signaling pathway was distinct from opioid receptor signaling and efficiently counteracted opioid-induced depression of breathing and consequential apnea in mice. Paradoxically, this rescue of breathing originated from enhanced glycinergic synaptic inhibition of glutamatergic and glycinergic neurons and caused disinhibition of their target neurons. Together, these effects changed respiratory phase alternations and ensured rhythmic breathing in vivo. GlyRα3-deficient mice had an irregular respiratory rhythm under baseline conditions, and systemic 5-HTR1A activation failed to remedy opioid-induced respiratory depression in these mice. Delineation of this 5-HTR1A–GlyRα3 signaling pathway offers a mechanistic basis for pharmacological treatment of opioid-induced apnea and other breathing disturbances caused by disorders of inhibitory synaptic transmission, such as hyperekplexia, hypoxia/ischemia, and brainstem infarction.

Authors

Till Manzke, Marcus Niebert, Uwe R. Koch, Alex Caley, Steffen Vogelgesang, Swen Hülsmann, Evgeni Ponimaskin, Ulrike Müller, Trevor G. Smart, Robert J. Harvey, Diethelm W. Richter

×

Figure 1

Expression of GlyRα3 in the brainstem.

Options: View larger image (or click on image) Download as PowerPoint
Expression of GlyRα3 in the brainstem.
GlyRα3 immunoreactivity (GlyRα3-I...
GlyRα3 immunoreactivity (GlyRα3-IR) showed almost-ubiquitous expression in the brainstem. Although there was no coexpression of GlyRα3 in motor nuclei like the facial nucleus (VII; A) and hypoglossal nucleus (XII; D) with GlyT2-eGFP neurons, GlyRα3 was expressed on glycinergic neurons within the BötC (B), pre-BötC (C), and spinal trigeminal nucleus (Sp5; E). Higher-magnification views of the merged images are shown at right. Scale bars: 200 μm (A and D); 100 μm (B, C, and E); 50 μm (higher magnification). AP, area postrema; IOPr, principal nucleus of the inferior olive; NA, nucleus ambiguus; NTS, nucleus of the solitary tract; RVLM, rostral ventrolateral medulla.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts